| dc.contributor.author |
Taliyan, Rajeev |
|
| dc.date.accessioned |
2023-12-12T10:38:28Z |
|
| dc.date.available |
2023-12-12T10:38:28Z |
|
| dc.date.issued |
2011-12 |
|
| dc.identifier.uri |
https://link.springer.com/article/10.1007/s10787-011-0106-4 |
|
| dc.identifier.uri |
http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13374 |
|
| dc.description.abstract |
Diabetes-induced neuropathic pain is recognized as one of the most difficult type of pain to treat and conventional analgesics are well known to be partially effective or associated with potential toxicity. Recently, it has been demonstrated that thalidomide, besides its teratogenic potential, reduced chronic pain in an SNL experimental pain model. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.publisher |
Springer |
en_US |
| dc.subject |
Pharmacy |
en_US |
| dc.subject |
STZ-induced-neuropathic |
en_US |
| dc.subject |
Diabetes |
en_US |
| dc.title |
Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats |
en_US |
| dc.type |
Article |
en_US |